Bio-Path Holdings, Inc. (BPTH) Social Stream
BIO-PATH HOLDINGS INC (BPTH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BIO-PATH HOLDINGS INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-03-14 | 1 | $13 | $12 | $12.5 | $0.534 | 2240.82% |
2022-05-17 | 2 | $13 | $12 | $12.5 | $0.534 | 2240.82% |
2023-03-17 | 2 | $13 | $9 | $11 | $0.534 | 1959.93% |
2023-05-12 | 1 | $13 | $13 | $13 | $0.534 | 2334.46% |
2023-08-15 | 1 | $12 | $12 | $12 | $0.534 | 2147.19% |
Price Target Last Issued August 15, 2023
The Trend in the Analyst Price Target
Over the past 25 months, BPTH's average price target has gone down $0.5.
BPTH reports an average of 1,318.83% for its upside potential over the past 151 days.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-03-17 | 1 | 13 | 13 | 13 | 1.560 | 733.33% |
2023-03-17 | 2 | 13 | 9 | 11 | 1.560 | 605.13% |
2023-03-17 | 1 | 13 | 9 | 11 | 1.560 | 605.13% |
2023-08-10 | 1 | 12 | 12 | 12 | 0.427 | 2710.3% |
2023-08-15 | 1 | 12 | 12 | 12 | 0.379 | 3066.23% |
BPTH Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 52 weeks, BPTH's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BPTH as an investment opportunity.
- BIO-PATH HOLDINGS INC's number of analysts covering the stock is higher than 5.86% of all US stocks.
- In the context of all US stocks, BIO-PATH HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 590.84% of them.
- In terms of how BIO-PATH HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 47.74% of that group.
- In the context of Healthcare stocks, BIO-PATH HOLDINGS INC's average analyst price target is greater than 127.94% of them.
In the Pharmaceutical Products industry, ONTX, ADXS, and NWBO are the three stocks most similar to BIO-PATH HOLDINGS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for BPTH? Use POWR Ratings for clearer insight into price direction.